Skip to content

Effect of Eucommia ulmoides capsule on 24-hour blood pressure rhythm in patients with essential hypertension

Effect of Eucommia ulmoides capsule on 24-hour blood pressure rhythm in patients with essential hypertension

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046830
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential hypertension

Interventions

Sponsors

Institute of Basic Theory of Chinese Medicine, China Academy of Chinese Medicine Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-75 years, male or female; 2. Meet the diagnostic criteria of essential hypertension; 3. 24-hour blood pressure rhythm is non-spoon type; 4. The regimen of western medicine for hypertension is stable (more than 3 months); 5. Voluntarily participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. People who are known or suspected to be allergic to experimental drugs and their components; 2. Patients with familial hypertension, malignant hypertension, hypertensive emergency, hypertensive crisis and hypertensive encephalopathy; 3. There is evidence of secondary hypertension, including but not limited to the following diseases: unilateral or bilateral renal artery stenosis, polycystic kidney disease, aldosteronism, coarctation of the aorta, Cushing syndrome, pheochromocytoma. 4. Gastrointestinal lesions or gastrointestinal surgery may affect drug absorption or excretion, such as gastroenterectomy, active gastrointestinal inflammation within nearly 3 months, ulcers or gastrointestinal bleeding; 5. Lifestyle with day and night reversal, or irregular sleep patterns; 6. People with a history of alcohol or drug abuse; 7. Inability to cooperate because of neurological or mental disorders; 8. Pregnant, lactating women or people with recent fertility plans; 9. The researchers do not think it is appropriate to participate in this clinical trial; 10. They have participated in other clinical trials within 3 months before the trial.

Design outcomes

Primary

MeasureTime frame
Spoon blood pressure recovery rate;Blood pressure variability index;Effective rate of blood pressure reduction(clinic blood pressure);

Secondary

MeasureTime frame
Changes of home blood pressure monitoring compared with baseline ;Changes of clinic blood pressure relative to baseline;The rate of reaching the standard rate of blood pressure in the clinic;

Countries

China

Contacts

Public ContactHu Jingqing

Institute of Basic Theory of Chinese Medicine, China Academy of Chinese Medicine Science

gcp306@126.com+86 13911546633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026